Heritage & History

We enhance lives by providing innovative,
safe and effective healthcare solutions

Heritage & History

We enhance lives by providing innovative,
safe and effective healthcare solutions

Heritage & History

We enhance lives by providing innovative,
safe and effective healthcare solutions

The Schillers Septodont is a pharmaceutical and medical device company and was founded in 1932 by Annie & Nestor Schiller. When Henri Schiller took the leadership of the company, Septodont launched worldwide well established brands such as Endomethasone, Alvogyl and Detartrine. At the same time, the group also positioned itself among the frontrunners of dental anaesthetics in cartridges and leader in anesthesia. To do so, Septodont acquired in 1990 a manufacturing site in France dedicated to dental needles. Then the company introduced Septocaine® in 2000 in the United States, the very first articaine-based anesthetic. In 2000, Septodont acquired Novocol, an injectable anaesthetic facility based in Canada.

Beyond dental anesthesia, Septodont also invested in R&D towards bioactive and biocompatible therapeutic solutions, which led to the introduction of Biodentine and Bioroot RCS, two products based on the ABS Technology (Active Biosilicate Technology).

The Schillers

Septodont is a pharmaceutical and medical device company and was founded in 1932 by Annie & Nestor Schiller. When Henri Schiller took the leadership of the company, Septodont launched worldwide well established brands such as Endomethasone, Alvogyl and Detartrine. At the same time, the group also positioned itself among the frontrunners of dental anaesthetics in cartridges and leader in anesthesia. To do so, Septodont acquired in 1990 a manufacturing site in France dedicated to dental needles. Then the company introduced Septocaine® in 2000 in the United States, the very first articaine-based anesthetic. In 2000, Septodont acquired Novocol, an injectable anaesthetic facility based in Canada.

Beyond dental anesthesia, Septodont also invested in R&D towards bioactive and biocompatible therapeutic solutions, which led to the introduction of Biodentine and Bioroot RCS, two products based on the ABS Technology (Active Biosilicate Technology).